Statera Biopharma, Inc. (STAB)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Aug 15, 2025, 11:49 AM EDT
Statera Biopharma Market Cap
Statera Biopharma has a market cap or net worth of $7.26 thousand as of August 15, 2025. Its market cap has decreased by -83.33% in one year.
Market Cap
7.26K
Enterprise Value
n/a
Revenue
3.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since July 28, 2021, Statera Biopharma's market cap has decreased from 170.15M to 7.26K, a decrease of -100.00%. That is a compound annual growth rate of -91.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 7.26K | - |
| Dec 31, 2024 | 7.26K | -83.33% |
| Dec 29, 2023 | 43.55K | -99.02% |
| Dec 30, 2022 | 4.44M | -93.99% |
| Dec 31, 2021 | 73.82M | -56.61% |
| Jul 28, 2021 | 170.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 567.91M |
| Elite Pharmaceuticals | 567.29M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 362.70M |
| CytoDyn | 344.75M |